Summit Therapeutics Inc (SMMT)
19.00
+0.58
(+3.15%)
USD |
NASDAQ |
Nov 22, 16:00
19.02
+0.02
(+0.11%)
After-Hours: 20:00
Summit Therapeutics PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| July 30, 2019 | 6.937 |
| July 29, 2019 | 7.413 |
| July 26, 2019 | 7.610 |
| July 25, 2019 | 7.413 |
| July 24, 2019 | 7.276 |
| July 23, 2019 | 7.096 |
| July 22, 2019 | 6.672 |
| July 19, 2019 | 6.937 |
| July 18, 2019 | 6.937 |
| July 17, 2019 | 6.856 |
| July 16, 2019 | 7.125 |
| July 15, 2019 | 7.148 |
| July 12, 2019 | 7.096 |
| July 11, 2019 | 7.148 |
| July 10, 2019 | 7.148 |
| July 09, 2019 | 7.678 |
| July 08, 2019 | 6.884 |
| July 05, 2019 | 6.831 |
| July 03, 2019 | 6.619 |
| July 02, 2019 | 7.519 |
| July 01, 2019 | 6.937 |
| June 28, 2019 | 6.700 |
| June 27, 2019 | 6.937 |
| June 26, 2019 | 7.307 |
| June 25, 2019 | 7.672 |
| Date | Value |
|---|---|
| June 24, 2019 | 7.837 |
| June 21, 2019 | 7.837 |
| June 20, 2019 | 7.731 |
| June 19, 2019 | 7.610 |
| June 18, 2019 | 7.572 |
| June 17, 2019 | 7.440 |
| June 14, 2019 | 6.566 |
| June 13, 2019 | 6.672 |
| June 12, 2019 | 7.519 |
| June 11, 2019 | 7.625 |
| June 10, 2019 | 8.049 |
| June 07, 2019 | 8.102 |
| June 06, 2019 | 7.943 |
| June 05, 2019 | 8.049 |
| June 04, 2019 | 8.022 |
| June 03, 2019 | 8.102 |
| May 31, 2019 | 8.049 |
| May 30, 2019 | 7.943 |
| May 29, 2019 | 8.049 |
| May 28, 2019 | 8.208 |
| May 24, 2019 | 8.419 |
| May 23, 2019 | 8.578 |
| May 22, 2019 | 8.684 |
| May 21, 2019 | 9.002 |
| May 20, 2019 | 9.055 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| Merck & Co Inc | 20.79 |
| Terns Pharmaceuticals Inc | -- |
| Instil Bio Inc | -- |
| Viking Therapeutics Inc | -- |
| Moderna Inc | -- |
PE Ratio Related Metrics
| PS Ratio | 14100.10 |
| Price to Book Value | 32.00 |
| Price | 19.00 |
| Earnings Yield | -1.26% |
| Market Cap | 14.01B |